Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK

PURPOSE: Among a cohort of postmenopausal breast cancer survivors, we aimed to compare the risk of dementia associated with aromatase inhibitor (AI) therapy versus tamoxifen. METHODS: Using UK primary care electronic health records, we identified 14,214 postmenopausal breast cancer survivors (aged ≥...

Descripción completa

Detalles Bibliográficos
Autores principales: Bromley, Susan E., Matthews, Anthony, Smeeth, Liam, Stanway, Susannah, Bhaskaran, Krishnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776493/
https://www.ncbi.nlm.nih.gov/pubmed/31321612
http://dx.doi.org/10.1007/s11764-019-00782-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776493/
https://www.ncbi.nlm.nih.gov/pubmed/31321612
http://dx.doi.org/10.1007/s11764-019-00782-w

Ejemplares similares